DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 161 filers reported holding DEPOMED INC in Q4 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $410,000 | +412.5% | 61,464 | +409.4% | 0.00% | – |
Q1 2018 | $80,000 | -75.6% | 12,067 | -70.2% | 0.00% | -100.0% |
Q4 2017 | $328,000 | -6.8% | 40,556 | -32.9% | 0.00% | 0.0% |
Q3 2017 | $352,000 | +10.3% | 60,403 | +102.7% | 0.00% | -50.0% |
Q2 2017 | $319,000 | -12.8% | 29,794 | +1.4% | 0.00% | 0.0% |
Q1 2017 | $366,000 | +72.6% | 29,394 | +151.1% | 0.00% | +100.0% |
Q4 2016 | $212,000 | -72.7% | 11,708 | -62.5% | 0.00% | -80.0% |
Q3 2016 | $776,000 | -10.4% | 31,200 | -29.1% | 0.01% | -16.7% |
Q2 2016 | $866,000 | +2693.5% | 44,000 | +1900.0% | 0.01% | – |
Q1 2016 | $31,000 | -92.4% | 2,200 | -90.2% | 0.00% | -100.0% |
Q4 2015 | $409,000 | -58.9% | 22,563 | -57.2% | 0.00% | -55.6% |
Q3 2015 | $995,000 | +175.6% | 52,734 | +213.9% | 0.01% | +125.0% |
Q2 2015 | $361,000 | +147.3% | 16,800 | +160.0% | 0.00% | +300.0% |
Q1 2015 | $146,000 | +224.4% | 6,461 | +133.6% | 0.00% | – |
Q4 2014 | $45,000 | – | 2,766 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 2,252,402 | $31,376,000 | 7.88% |
Healthcare Value Capital, LLC | 350,000 | $4,876,000 | 7.16% |
Senvest Management, LLC | 4,977,256 | $69,333,000 | 5.82% |
Consonance Capital Management LP | 2,756,360 | $38,396,000 | 5.81% |
Opaleye Management Inc. | 325,000 | $4,527,000 | 2.82% |
Krensavage Asset Management, LLC | 447,000 | $6,227,000 | 2.23% |
Healthcare Value Capital, LLC | 100,000 | $1,393,000 | 2.05% |
Starboard Value LP | 2,950,000 | $41,094,000 | 1.44% |
HealthInvest Partners AB | 200,000 | $2,786,000 | 1.30% |
OAK RIDGE INVESTMENTS LLC | 7,206,286 | $100,384,000 | 1.29% |